Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Isoplexis Corp.
Headquarters: Branford, CT, United States of America
Website: N/A
Year Founded: 2013
Status: Acquired
BioCentury | Dec 24, 2022
BioCentury Commentary
Noisemakers and newsmakers of 2022, and hot takes for 2023
BioCentury’s analysts look back at a year when industry took some slings and arrows but delivered breakthroughs, and predict what’ll be hot in 2023
BioCentury | Dec 23, 2022
Deals
Dec. 22 Quick Takes: Mersana picks Merck KGaA for its third ADC deal of 2022
Plus: Lilly builds on genetic medicine focus with ProQR deal and Stifel buying Torreya; Gilead; lecanemab; ORIC-Pfizer and more
BioCentury | Oct 8, 2021
Finance
Nearing $30B in 2021, global biotech IPOs on pace to top record
IPOs by Pyxis, IsoPlexis and Cognition bring October’s tally to almost $900M in fresh paper
BioCentury | Jul 11, 2020
Management Tracks
Andrews joins Akcea as CMO; plus changes at Strongbridge, Abeona, Lyra, Kronos and more
BioCentury | May 16, 2020
Management Tracks
Management Tracks: Evox, Phoenix Tissue Repair, Artax, Nucleix, IsoPlexis, Centogene, Immunicum, CohBar and CorMedix
BioCentury | May 15, 2019
Financial News
May 15 Financial Quick Takes: Perceptive leads $60M round for ArcherDx; plus Applied Therapeutics’ IPO, IsoPlexis, Symphogen
Items per page:
1 - 8 of 8